Spring Valley Acquisition Corp. IV (NASDAQ:SVIV – Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 13 shares, a decrease of 87.5% from the September 30th total of 104 shares. Based on an average daily volume of 43,073 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are sold short.
Spring Valley Acquisition Corp. IV Stock Up 0.5%
Shares of NASDAQ:SVIV traded up $0.06 during midday trading on Tuesday, reaching $10.13. The company’s stock had a trading volume of 226,671 shares, compared to its average volume of 60,322. The stock has a fifty day moving average of $10.16 and a 200 day moving average of $10.11. Spring Valley Acquisition Corp. IV has a twelve month low of $9.55 and a twelve month high of $10.80.
Analyst Ratings Changes
Separately, Weiss Ratings raised shares of Spring Valley Acquisition Corp. IV from a “sell (e)” rating to a “sell (e+)” rating in a research note on Wednesday, September 9th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock currently has an average rating of “Sell”.
Read Our Latest Research Report on SVIV
Spring Valley Acquisition Corp. IV Company Profile
Spring Valley Acquisition Corp. IV is a special purpose acquisition company (SPAC) listed on the Nasdaq under the symbol SVIV. The company was formed to raise capital through an initial public offering and use those funds to pursue a business combination, such as a merger, acquisition, or similar transaction.
Unlike an operating company, Spring Valley Acquisition Corp. IV does not have established products, services, or ongoing commercial operations. Its activities are primarily focused on identifying a suitable target company and completing an initial business combination.
Featured Articles
- Five stocks we like better than Spring Valley Acquisition Corp. IV
- Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
- Merck and Moderna’s Cancer Vaccine Worked—Who Gets Paid?
- Intel’s $155 Price Target Raises a Bigger Question About Its Turnaround Potential
Receive News & Ratings for Spring Valley Acquisition Corp. IV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spring Valley Acquisition Corp. IV and related companies with MarketBeat.com's FREE daily email newsletter.
